Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Recurrence × tisagenlecleucel × Clear all

Status

Completed 4 Active not recruiting 2 Withdrawn 1 Terminated 1 Recruiting 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

3-Iodobenzylguanidine 2 tisagenlecleucel 1 Immunotherapy, Adoptive 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03601442 2025-12-05

CTL019 Out of Specification MAP for ALL or DLBCL Patients

Novartis

LymphoidOther hematologic neoplasm

Recurrence, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡